Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats.

Fisher M, Meadows ME, Do T, Weise J, Trubetskoy V, Charette M, Finklestein SP.

J Cereb Blood Flow Metab. 1995 Nov;15(6):953-9.

PMID:
7593356
[PubMed - indexed for MEDLINE]
Free Article
2.

Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.

Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M.

J Neurol Sci. 1996 Aug;139(2):173-9.

PMID:
8856649
[PubMed - indexed for MEDLINE]
4.

Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.

Tatlisumak T, Takano K, Carano RA, Fisher M.

Stroke. 1996 Dec;27(12):2292-7; discussion 2298.

PMID:
8969796
[PubMed - indexed for MEDLINE]
Free Article
5.

Intravenous basic fibroblast growth factor produces a persistent reduction in infarct volume following permanent focal ischemia in rats.

Sugimori H, Speller H, Finklestein SP.

Neurosci Lett. 2001 Mar 2;300(1):13-6.

PMID:
11172928
[PubMed - indexed for MEDLINE]
6.

Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia.

Ren JM, Finklestein SP.

Eur J Pharmacol. 1997 May 26;327(1):11-6.

PMID:
9185830
[PubMed - indexed for MEDLINE]
7.

Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats.

Koketsu N, Berlove DJ, Moskowitz MA, Kowall NW, Caday CG, Finklestein SP.

Ann Neurol. 1994 Apr;35(4):451-7.

PMID:
8154872
[PubMed - indexed for MEDLINE]
8.

Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model.

Tanaka R, Miyasaka Y, Yada K, Ohwada T, Kameya T.

Stroke. 1995 Nov;26(11):2154-8; discussion 2158-9.

PMID:
7482665
[PubMed - indexed for MEDLINE]
Free Article
9.

Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat.

Kawamata T, Alexis NE, Dietrich WD, Finklestein SP.

J Cereb Blood Flow Metab. 1996 Jul;16(4):542-7.

PMID:
8964792
[PubMed - indexed for MEDLINE]
Free Article
10.

Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.

Schäbitz WR, Schwab S, Spranger M, Hacke W.

J Cereb Blood Flow Metab. 1997 May;17(5):500-6.

PMID:
9183287
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats.

Wada K, Sugimori H, Bhide PG, Moskowitz MA, Finklestein SP.

Stroke. 2003 Nov;34(11):2722-8. Epub 2003 Oct 23.

PMID:
14576381
[PubMed - indexed for MEDLINE]
Free Article
12.

bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice.

Huang Z, Chen K, Huang PL, Finklestein SP, Moskowitz MA.

Am J Physiol. 1997 Mar;272(3 Pt 2):H1401-5.

PMID:
9087617
[PubMed - indexed for MEDLINE]
13.

Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats.

Dietrich WD, Alonso O, Busto R, Finklestein SP.

J Neurotrauma. 1996 Jun;13(6):309-16.

PMID:
8835798
[PubMed - indexed for MEDLINE]
14.

Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.

Schäbitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S.

Stroke. 2000 Sep;31(9):2212-7.

PMID:
10978054
[PubMed - indexed for MEDLINE]
Free Article
15.

Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia.

Schäbitz WR, Li F, Irie K, Sandage BW Jr, Locke KW, Fisher M.

Stroke. 1999 Feb;30(2):427-31; discussion 431-2.

PMID:
9933283
[PubMed - indexed for MEDLINE]
Free Article
16.

Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector.

Song BW, Vinters HV, Wu D, Pardridge WM.

J Pharmacol Exp Ther. 2002 May;301(2):605-10.

PMID:
11961063
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

The effect of ritanserin, a 5-HT2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion.

Takagi K, Ginsberg MD, Globus MY, Busto R, Dietrich WD.

Stroke. 1994 Feb;25(2):481-5; discussion 485-6.

PMID:
8303760
[PubMed - indexed for MEDLINE]
19.

Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH 2nd.

J Neurol Sci. 2001 Jun 15;187(1-2):91-7.

PMID:
11440750
[PubMed - indexed for MEDLINE]
20.

Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.

Huh PW, Belayev L, Zhao W, Clemens JA, Panetta JA, Busto R, Ginsberg MD.

Eur J Pharmacol. 2000 Feb 11;389(1):79-88.

PMID:
10686299
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk